Idera Pharmaceuticals, Inc. (IDRA) was a big mover last session, as the company saw its shares surge nearly 18% on the day. This rally higher can be attributable to solid volume with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock is now down about 19% in the past one-month time frame.
In the last 30 days, the company witnessed 1 downward estimate revision, while the Zacks Consensus Estimate, pegged at a loss, widened over the same timeframe, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent high can last.
Idera Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), ANI Pharmaceuticals, Inc. (ANIP) and Aastrom Biosciences, Inc. (ASTM) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
IDERA PHARMACEUTICALS INC (IDRA): Free Stock Analysis Report
(ALIOF): Free Stock Analysis Report
AASTROM BIOSCIENCES INC (ASTM): Free Stock Analysis Report
ANI PHARMACEUTICALS INC (ANIP): Free Stock Analysis Report
Zacks Investment Research
- Health Care Industry
- Finance Trading